Species-specific serodiagnosis of lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A

Journal of Clinical Microbiology

Volumn 40, Issue 2, 2002, Pages 453-460

  Heikkilä, Tero ^a   Seppälä, Ilkka ^a   Saxen, Harri ^a   Panelius, Jaana ^a   Yrjänäinen, Heta ^a   Lahdenne, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DECORIN;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; BACTERIUM IDENTIFICATION; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA INFECTION; GENBANK; LYME DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SERODIAGNOSIS;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP; CARRIER PROTEINS; HUMANS; IMMUNOBLOTTING; LYME DISEASE; LYME NEUROBORRELIOSIS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII;

EID: 0036159409     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.02.453-460.2002     Document Type: Article

References (43)

1. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis
2. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity
3. Clinical evaluation of guidelines and two-test approach for Lyme disease
4. Adherence of Borrelia burgdorferi. Identification of critical lysine residues in DbpA required for decorin binding
5. Role of serology in the diagnosis of Lyme disease
6. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies
7. Evidence of Dbps (decorin binding proteins) among European strains of Borrelia burgdorferi sensu lato and in the immune response of LB patient sera
8. Amino acid sequence heterogeneity of chromosomal encoded Borrelia burgdorferi sensu lato major antigen P100
9. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice
10. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease
11. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis
12. Adherence of Borrelia burgdorferi to the proteoglycan decorin
13. Decorin-binding adhesins from Borrelia burgdorferi
14. Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis
15. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection
16. Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of Lyme borreliosis
17. Enzyme-linked immunosorbent assays with recombinant internal flagellin fragments derived from different species of Borrelia burgdorferi sensu lato for the serodiagnosis of Lyme neuroborreliosis
18. Impact of strain heterogeneity on Lyme disease serology in Europe: Comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato
19. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe
20. Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe
21. Genetic heterogeneity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi
22. Osp17, a novel immunodominant outer surface protein of Borrelia afzelii: Recombinant expression in Escherichia coli and its use as a diagnostic antigen for serodiagnosis of Lyme borreliosis
23. Prevalence of Borrelia burgdorferi in selected tick populations in Finland
24. Prevalence of Borrelia burgdorferi in Ixodes ricinus ticks in urban recreational areas of Helsinki
25. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi
26. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE
27. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis
28. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens
29. Lyme borreliosis
30. Characterization of the cellular and humoral immune response to outer surface protein C and outer surface protein 17 in children with early disseminated Lyme borreliosis
31. Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease
32. Enzymelinked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease
33. Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorfen sensu lato
34. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis
35. Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis
36. Diagnosis of Lyme borreliosis: Non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies
37. Pitfalls in the diagnosis and management of Lyme disease
38. Borrelia burgdorferi (Lyme disease, Lyme borreliosis)
39. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period
40. Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies
41. Molecular typing of Borrelia burgdorferi sensu lato: Taxonomic, epidemiologic, and clinical implications
42. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis
43. Improving the yield of blood cultures for patients with early Lyme disease